G2GBio

456160· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩36,000+1.12%

2026-11-02

Financials

Valuation Metrics

G2GBio's Market Cap is ₩6012B. At end of 2025 it was ₩1.1T. Ranked #394 of 2,410 in KR market (top 16%), #133 of 1,631 on KOSDAQ (top 8%), #42 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 18%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	601.15B KRW	KR#394/2,410 Sec#42/231
Revenue	2.22B KRW	KR#2,370/2,410 Sec#213/231
Net Income	-17.58B KRW	KR—/2,410 Sec—/231
Total Assets	235.05B KRW	KR#1,193/2,410 Sec#84/231
Net Assets	139.02B KRW	KR#1,183/2,410 Sec#89/231
Value
P/B	4.31x	KR#2,227/2,410 Sec#192/231
P/S	270.22x	KR#2,394/2,410 Sec#220/231
FCF Yield	-2.37%	KR—/2,410 Sec—/231
Profitability
ROE	-12.65%	KR#1,983/2,410 Sec#151/231
ROA	-7.48%	KR#2,030/2,410 Sec#149/231
Op. Margin	-568.74%	KR#2,357/2,410 Sec#207/231
Revenue Growth	-44.98%	KR#2,268/2,410 Sec#202/231
Financial Health
Debt Ratio	69.08%	KR#1,203/2,410 Sec#146/231
Total Debt	40.82B KRW	KR#1,083/2,410 Sec#75/231
FCF	-14.23B KRW	KR#1,801/2,410 Sec#166/231
Cash	12.07B KRW	KR#1,577/2,410 Sec#132/231
Current Ratio	2.38x	KR#722/2,410 Sec#86/231
Performance
1Y Return	-35.36%	KR#1,701/2,410 Sec#138/231
1M Return	-17.43%	KR#361/2,410 Sec#36/231
From 52W High	-70.97%	KR#2,085/2,410 Sec#176/231
1Y MDD	-80.68%	KR#2,294/2,410 Sec#205/231
Trading
Volume	279,147 shares	KR#452/2,410 Sec#51/231
Trading Value	10.38B KRW	KR#274/2,410 Sec#22/231
Foreign Own.	5.69%	KR#767/2,410 Sec#71/231
Per Share
EPS	-1,057 KRW	KR—/2,410 Sec—/231
BPS	8,360 KRW	KR#1,114/2,410 Sec#79/231